Literature DB >> 22122656

Relations between childhood traumatic experiences, dissociation, and cognitive models in obsessive compulsive disorder.

Yavuz Selvi1, Lutfullah Besiroglu, Adem Aydin, Mustafa Gulec, Abdullah Atli, Murat Boysan, Cihat Celik.   

Abstract

OBJECTIVE: Previous studies have indicated that obsessive compulsive disorder (OCD) is associated with childhood traumatic experiences and higher levels of dissociation. Dissociative tendency may arise when individual attempt to incorporate adverse experiences into cognitive schema.
METHODS: We investigated the possible links among childhood trauma, dissociation, and cognitive processes. We evaluated 95 patients with OCD using the Beck Depression Inventory (BDI), Thought-Action Fusion Scale (TAFS), Metacognitions Questionnaire (MCQ-30), White Bear Suppression Inventory (WBSI), Dissociative Experiences Scale (DES), and Childhood Trauma Questionnaire (CTQ-28).
RESULTS: The CTQ-28 total scores were not associated with Y-BOCS total, Y-BOCS insight, BDI, TAFS, MCQ-30, and WBSI scores. The TAFS Total, MCQ-30, WBSI, and BDI scores were significantly associated with DES scores. Regression analysis revealed that MCQ-30 and WBSI scores significantly predicted the DES scores.
CONCLUSIONS: These results suggest that in spite of pathological connotation of dissociative experiences, dissociation may primarily constitute a cognitive trait which is strongly associated with cognitive processes.

Entities:  

Mesh:

Year:  2011        PMID: 22122656     DOI: 10.3109/13651501.2011.617458

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  9 in total

1.  Development and Preliminary Psychometric Properties of an Instrument for the Measurement of Obsessional Dissociative Experiences: The Van Obsessional Dissociation Questionnaire (VOD-Q).

Authors:  Murat Boysan; Abdullah Yıldırım; Lütfullah Beşiroğlu; Mehmet Celal Kefeli; Mücahit Kağan
Journal:  Psychiatr Q       Date:  2018-09

2.  Dissociative Experiences are Associated with Obsessive-Compulsive Symptoms in a Non-clinical Sample: A Latent Profile Analysis.

Authors:  Murat Boysan
Journal:  Noro Psikiyatr Ars       Date:  2014-09-01       Impact factor: 1.339

Review 3.  Dissociative symptoms and dissociative disorders comorbidity in obsessive compulsive disorder: Symptom screening, diagnostic tools and reflections on treatment.

Authors:  Hasan Belli
Journal:  World J Clin Cases       Date:  2014-08-16       Impact factor: 1.337

4.  Are trauma and dissociation related to treatment resistance in patients with obsessive-compulsive disorder?

Authors:  Umit B Semiz; Leman Inanc; Cigdem H Bezgin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-11-09       Impact factor: 4.328

5.  Evaluation of Relationship between Obsessive-compulsive Disorder and Dissociative Experiences.

Authors:  Mustafa Tatlı; Ozlem Cetinkaya; Fulya Maner
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-05-31       Impact factor: 2.582

6.  Impact of childhood maltreatment on obsessive-compulsive disorder symptom severity and treatment outcome.

Authors:  Sabrina Boger; Thomas Ehring; Götz Berberich; Gabriela G Werner
Journal:  Eur J Psychotraumatol       Date:  2020-06-08

7.  Association Between Childhood Maltreatment and Symptoms of Obsessive-Compulsive Disorder: A Meta-Analysis.

Authors:  Wenwen Ou; Zhijun Li; Qi Zheng; Wentao Chen; Jin Liu; Bangshan Liu; Yan Zhang
Journal:  Front Psychiatry       Date:  2021-01-20       Impact factor: 4.157

8.  Attention Deficit Hyperactivity Disorder, Impulsivity, Anxiety, and Depression Symptoms Mediating the Relationship Between Childhood Trauma and Symptoms Severity of Obsessive-Compulsive Disorder.

Authors:  Adnan Çoban; Oğuz Tan
Journal:  Noro Psikiyatr Ars       Date:  2019-08-16       Impact factor: 1.339

9.  Dissociative features of fibromyalgia syndrome.

Authors:  Tonguc D Berkol; Yasin H Balcioglu; Simge S Kirlioglu; Habib Erensoy; Meltem Vural
Journal:  Neurosciences (Riyadh)       Date:  2017-07       Impact factor: 0.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.